ACHC Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, NEC · Nasdaq · SEC CIK 1520697 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY4.5%
TTM net income YoY-1,150.7%
TTM EPS YoY-1,154.2%
Revenue 3-yr CAGR6.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin-33.1%
FCF margin-0.7%
EBITDA margin—
Returns
ROE-43.9%
ROA-18.9%
ROIC (approx.)—
Asset turnover0.57x
Leverage & solvency
Liabilities / assets59.5%
Debt / equity1.16x
Current ratio1.60x
Interest coverage—
Cash quality & payout
Operating cash flow / net income-0.21x
Accruals ratio-22.8%
Payout ratio—
Capex / revenue7.6%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $895.31M | $865.84M | $828.80M | $821.46M | $851.57M | $869.23M | $770.50M | $774.24M |
| Pretax income | $56.47M | $22.01M | $10.96M | -$1.17B | $39.98M | $50.00M | $13.47M | $38.01M |
| Income tax | $17.82M | $9.75M | $6.50M | $7.84M | $1.67M | $12.07M | $4.40M | $4.48M |
| Net income | $34.49M | $10.93M | $4.11M | -$1.18B | $36.25M | $30.13M | $8.37M | $32.62M |
| EPS (basic) | 0.38 | 0.12 | 0.05 | — | 0.40 | 0.33 | 0.09 | — |
| EPS (diluted) | 0.38 | 0.12 | 0.05 | — | 0.40 | 0.33 | 0.09 | — |
| Weighted avg. shares (diluted) | 91.75M | 91.37M | 90.86M | — | 90.58M | 90.44M | 92.04M | — |
| Banking | ||||||||
| Net interest income | -$37.28M | -$38.18M | -$38.33M | -$37.92M | -$36.62M | -$35.14M | -$29.18M | -$30.07M |
| Balance sheet | ||||||||
| Cash & equivalents | $163.31M | $171.29M | $158.47M | $133.24M | $118.69M | $131.42M | $91.24M | $76.31M |
| Receivables | $501.38M | $470.75M | $471.75M | $440.60M | $430.84M | $408.54M | $396.63M | $365.34M |
| Inventory | $6.25M | $6.26M | $5.93M | $5.69M | $6.25M | $5.82M | $5.71M | $5.65M |
| Current assets | $881.32M | $845.29M | $837.20M | $814.14M | $747.96M | $691.56M | $638.95M | $577.49M |
| PP&E, net | $3.05B | $3.09B | $3.11B | $3.11B | $3.09B | $3.06B | $2.96B | $2.85B |
| Goodwill | $1.32B | $1.30B | $1.30B | $1.30B | $2.29B | $2.28B | $2.28B | $2.26B |
| Intangibles | $100.19M | $100.19M | $98.58M | $96.67M | $85.18M | $79.47M | $78.83M | $70.00M |
| Total assets | $5.55B | $5.55B | $5.55B | $5.53B | $6.41B | $6.31B | $6.15B | $5.96B |
| Current liabilities | $552.03M | $537.58M | $489.36M | $525.19M | $517.92M | $523.71M | $473.35M | $577.92M |
| Short-term debt | $32.50M | $32.50M | $32.50M | $28.44M | $24.38M | $20.31M | $16.25M | $76.82M |
| Long-term debt | $2.32B | $2.38B | $2.49B | $2.47B | $2.28B | $2.25B | $2.18B | $1.88B |
| Total debt | $2.35B | $2.41B | $2.53B | $2.50B | $2.31B | $2.27B | $2.20B | $1.96B |
| Total liabilities | $3.30B | $3.35B | $3.38B | $3.39B | $3.12B | $3.08B | $2.97B | $2.77B |
| Shareholders' equity | $2.02B | $1.98B | $1.96B | $1.95B | $3.12B | $3.08B | $3.04B | $3.07B |
| Net debt | $2.19B | $2.24B | $2.37B | $2.37B | $2.19B | $2.14B | $2.11B | $1.88B |
| Shares outstanding | 90.91M | 90.87M | 90.76M | 90.45M | 90.43M | 90.39M | 90.39M | 91.78M |
| Cash flow statement | ||||||||
| Operating cash flow | $97.88M | $162.07M | $61.53M | -$86.29M | $73.21M | $133.50M | $11.48M | $116.70M |
| Capital expenditure | $50.74M | $38.55M | $76.56M | $93.19M | $136.24M | $167.75M | $174.63M | $203.49M |
| Free cash flow | $47.14M | $123.51M | -$15.03M | -$179.48M | -$63.03M | -$34.24M | -$163.15M | -$86.79M |
| Investing cash flow | -$42.51M | -$32.68M | -$60.21M | -$92.44M | -$129.75M | -$150.78M | -$183.24M | -$203.33M |
| Financing cash flow | -$63.36M | -$116.57M | $23.91M | $193.28M | $43.82M | $57.46M | $186.69M | $80.79M |
| Depreciation & amortization | $53.13M | $50.43M | $52.43M | $45.75M | $47.47M | $48.99M | $47.03M | $39.54M |
| Stock-based compensation | $9.25M | $10.99M | $7.96M | $6.45M | $6.03M | $10.55M | $8.68M | $10.10M |
| Share buybacks | — | — | — | $0 | $0 | $3.15M | $46.88M | — |
Free plan shows the latest 8 periods; Pro shows all 65 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.